2015-2019 Global Cyclospora Testing Market: Sales Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - US, Europe (France, Germany, Italy, Spain, UK), Japan
![](/report_cover/2215/2015-2019-global-cyclospora-testing-market-sales-forecasts_en.gif)
The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health LabsFor each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Contains 191 pages and 7 tables
1. INTRODUCTION
2. CYCLOSPORA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
3. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
4. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
5. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
6. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
7. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
8. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
9. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
10. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
11. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
12. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
2. CYCLOSPORA WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
3. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
4. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
5. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
6. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
7. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
8. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
9. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
10. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
11. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
12. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
LIST OF TABLES
France Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
France Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Germany Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment